Figure 1From: Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort studyPlasma concentrations of 2-AG and AEA in Alzheimer's disease subjects (AD) and elderly controls (EC).Back to article page